Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'

Ann Rheum Dis. 2023 Feb;82(2):e34. doi: 10.1136/annrheumdis-2020-219479. Epub 2020 Dec 14.
No abstract available

Keywords: COVID-19; cytokines; interleukin 1 receptor antagonist protein.

Publication types

  • Letter

MeSH terms

  • COVID-19 Drug Treatment
  • COVID-19*
  • Cytokine Release Syndrome / drug therapy
  • Glucocorticoids / therapeutic use
  • Humans

Substances

  • Glucocorticoids
  • tocilizumab